Quality of life on randomized treatment for isolated systolic hypertension: results from the Syst-Eur Trial


Fletcher, AE; Bulpitt, CJ; Thijs, L; Tuomilehto, J; Antikainen, R; Bossini, A; Browne, J; Duggan, J; Kawecka-Jaszcz, K; Kivinen, P; Sarti, C; Terzoli, L; Staessen, JA; (2002) Quality of life on randomized treatment for isolated systolic hypertension: results from the Syst-Eur Trial. Journal of hypertension, 20 (10). pp. 2069-79. ISSN 0263-6352 DOI: https://doi.org/10.1097/00004872-200210000-00028

Full text not available from this repository. (Request a copy)

Abstract

OBJECTIVE: To compare quality of life in elderly patients with isolated systolic hypertension allocated randomly to groups to receive placebo or active treatment in the Systolic Hypertension in the Elderly Trial. DESIGN: Double-blind randomized controlled trial. METHODS: Patients aged 60 years were allocated randomly to groups to receive first-line treatment with nitrendipine (with second- and third-line enalapril and hydrochlorothiazide) or placebo. Trained interviewers administered trail-making tests (Trail A and B), Brief Assessment Index (a measure of depressed mood) and four subscales from the Sickness Impact Profile (Ambulation, Social Interaction, Sleep and Rest, and Home work). RESULTS: Six hundred and ten patients completed a baseline and at least one follow-up questionnaire. Trail-making scores were slower in actively treated patients, especially in the first 6 months of follow-up when the between-group effect sizes were 0.25 [95% confidence interval (CI) 0.07 to 0.43] for Trail-making A and 0.13 (95% CI -0.05 to 0.31) for Trail-making B. Across the 4 years of follow-up, patients receiving active treatment were more likely to report problems on the Social Interaction scale than were placebo-treated patients (odds ratio 1.32, 95% CI 1.02 to 1.69), equivalent to a 7% difference. There were no significant differences between active and placebo treatment in the other Sickness Impact Profile dimensions or in the measure of depression. CONCLUSIONS: Active treatment in the Systolic Hypertension in Europe trial was associated with some small adverse impacts on quality of life.

Item Type: Article
Keywords: Aged, Antihypertensive Agents/therapeutic use, Blood Pressure/drug effects/physiology, Comparative Study, Double-Blind Method, Europe/epidemiology, Female, Follow-Up Studies, Human, Hypertension/*drug therapy/*psychology, Male, Middle Age, Psychomotor Performance/drug effects/physiology, Quality of Life/*psychology, Questionnaires, Statistics, Support, Non-U.S. Gov't, Time Factors, Trail Making Test, Treatment Outcome
Faculty and Department: Faculty of Public Health and Policy > Dept of Health Services Research and Policy
Faculty of Epidemiology and Population Health > Dept of Non-Communicable Disease Epidemiology
PubMed ID: 12359987
Web of Science ID: 179174800028
URI: http://researchonline.lshtm.ac.uk/id/eprint/17015

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
301Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item